9 unknown. 9 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Unknown 9 |
| Phase 2 | 4 | Unknown 4 |
Follow Neuroblastoma: new trials by email Literature Review of Neuroblastoma trials Research Report on Neuroblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Study of BCD-245 in Subjects With Neuroblastoma BCD-245 - Neuroblastoma | Phase 1 | Unknown | Biocad | 24 | 2021-11-29 | 2023-03-24 |
| Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells Anti-GD2 in combination with NK cells - Neuroblastoma Recurrent | Phase 1 / Phase 2 | Unknown | National University Hospital, Singapore | 5 | 2017-10-03 | 2018-03-30 |
| T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies Cyclophosphamide, Fludarabine, Anti-NY ESO-1 TCR-transduced T cells - Bladder Carcinoma, Breast Cancer | Phase 1 | Unknown | Shenzhen Second People's Hospital | 36 | 2015-04-01 | 2016-08-03 |
| Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma IL-2, GD2Bi-aATC, GM-CSF - Disseminated Neuroblastoma, Recurrent Neuroblastoma | Phase 1 / Phase 2 | Unknown | University of Virginia | 40 | 2014-11-01 | 2019-01-29 |
| Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2) ch14.18/CHO, Aldesleukin, Isotretinoin - Neuroblastoma | Phase 1 / Phase 2 | Unknown | St. Anna Kinderkrebsforschung | 288 | 2012-01-01 | 2020-07-14 |
| 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma 131I-MIBG , Etoposide, Melphalan, Carboplatin, Autologous Peripheral Stem Cell Transplantation - Neuroblastoma | Phase 1 / Phase 2 | Unknown | Tehran University of Medical Sciences | 10 | 2008-09-01 | 2012-06-04 |
| Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections cytomegalovirus IE-1-specific cytotoxic T lymphocytes, cytomegalovirus pp65-specific cytotoxic T lymphocytes, therapeutic allogeneic lymphocytes - Cancer | Phase 1 | Unknown | Milton S. Hershey Medical Center | 20 | 2008-08-01 | 2013-12-18 |
| Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features Seneca Valley Virus (biological agent) - Carcinoid, Neuroendocrine | Phase 1 | Unknown | Neotropix | 60 | 2006-04-01 | 2010-02-25 |
| Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma aldesleukin, autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine, therapeutic autologous lymphocytes - Neuroblastoma, Sarcoma | Phase 1 | Unknown | Milton S. Hershey Medical Center | 10 | 2004-11-01 | 2013-12-18 |
Breast Neoplasms (2) · Multiple Myeloma (2) · Recurrence (2) · Wilms Tumor (2) · Blast Crisis (1) · Burkitt Lymphoma (1) · Carcinoid Tumor (1) · Carcinoma, Ovarian Epithelial (1) · Congenital Abnormalities (1) · Cytomegalovirus Infections (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Esophageal Neoplasms (1) · Glioblastoma (1) · Hodgkin Disease (1)
Neoplasms by Histologic Type (9) · Neoplasms, Germ Cell and Embryonal (9) · Neoplasms, Glandular and Epithelial (9) · Neoplasms, Nerve Tissue (9) · Neoplasms, Neuroepithelial (9) · Neuroectodermal Tumors (9) · Neuroectodermal Tumors, Primitive (9) · Neoplasms (8) · Neuroectodermal Tumors, Primitive, Peripheral (8) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Neoplasms by Site (3) · Neoplasms, Connective and Soft Tissue (3) · Urogenital Diseases (3)
aldesleukin (3) · Interleukin-2 (2) · 3-Iodobenzylguanidine (1) · Biological Factors (1) · Carboplatin (1) · Cyclophosphamide (1) · Etoposide (1) · Flow Cytometry (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · Isotretinoin (1) · Melphalan (1) · Polymerase Chain Reaction (1) · fludarabine (1) · sargramostim (1)
Milton S. Hershey Medical Center (2) · Biocad (1) · National University Hospital, Singapore (1) · Neotropix (1) · Shenzhen Second People's Hospital (1) · St. Anna Kinderkrebsforschung (1) · Tehran University of Medical Sciences (1) · University of Virginia (1)
United States (4) · Austria (1) · China (1) · France (1) · Germany (1) · Iran (1) · Israel (1) · Italy (1) · Russia (1) · Singapore (1) · Spain (1) · United Kingdom (1)
Kenneth G. Lucas, MD (2) · Dario Campana, MD, PhD (1) · Holger Lode, MD, PhD (1) · Maxim Yankelevich (1) · Miriam Kimpo, MD (1) · Rudin Charles, MD, PhD (1)
2009 (1), P30CA022453 (1)